In short - certain ones, yes. This should be one step (that was a bottleneck) in helping a company with a fixed budget do an order or magnitude more 'experiments' with the same amount of resources. Lab resources are expensive and fixed, so if you can pre-compute what you need, you can get right to the more powerful results.

We design proteins for immunotherapies - this kind of thing would help us more rapidly design our proteins (and more efficiently use our wet-lab resources to speed existing projects). For others, some drugs are hard build without knowing how they will interact - this could both provide new 'targets' to go after, but also might help prevent projects that would otherwise accidentally target an important protein.